A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer
Clinical trial NCT01189929 · COMPLETED
Trial details
- NCT number
- NCT01189929
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2016-12-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.